肺癌患者管理中的合并症
肺癌患者常合并多种疾病,影响诊断与治疗决策。重度肺气肿或弥漫性肺纤维化可能禁忌经胸穿刺活检,慢阻肺患者手术可能不可行或需先康复,间质性肺病患者有放射性肺炎风险且应避免加重呼吸功能不全的药物。老年或HIV感染等特殊人群需特定全身治疗,心理社会因素亦重要。
要点
- 肺癌患者合并症常见,诊断和治疗前需仔细评估。
- 重度肺气肿或弥漫性肺纤维化可能禁忌经胸穿刺活检。
- 慢阻肺患者手术可能不可行或需先强化康复。
核心结论
- 肺癌患者的合并症需在诊断和治疗决策前仔细评估,并影响活检、手术、放疗和全身治疗的选择。
研究设计与样本
- 原文为综述,未报告系统检索范围。
主要发现
- 超过一半的肺癌患者诊断时已处晚期。
- 重度肺气肿或弥漫性肺纤维化患者可能禁忌经胸穿刺活检,有时无法获得精确诊断。
- 慢阻肺患者手术可能不可行或应先进行强化康复。
- 间质性肺病患者有放射性肺炎风险,应避免使用可加重呼吸功能不全的药物。
- 老年或HIV感染等特殊人群应特别考虑全身治疗,心理社会因素因国家医保覆盖而异。
临床怎么用
- 肺癌诊疗决策前应系统评估合并症,包括肺气肿、肺纤维化、慢阻肺和间质性肺病。
- 对特殊人群如老年或HIV感染者,全身治疗需个体化。
- 关注心理社会因素及医保覆盖对治疗的影响。
局限性
- 原文为综述,未报告系统检索策略和证据等级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lung cancer represents a major public health issue worldwide. Unfortunately, more than half of them are diagnosed at an advanced stage. Moreover, even if diagnosed early, diagnosis procedures and treatment can be difficult due to the frequent comorbidities observed in these patients. Some of these comorbidities have a common major risk factor, i.e. smoking, whereas others are unrelated to smoking but frequently observed in the general population. These comorbidities must be carefully assessed before any diagnostic and/or therapeutic decisions are made regarding the lung cancer. For example, in a patient with severe emphysema or with diffuse lung fibrosis, transthoracic needle biopsy can be contraindicated, meaning that in some instances a precise diagnosis cannot be obtained; in a patient with chronic obstructive pulmonary disease, surgery may be impossible or should be preceded by intensive rehabilitation; patients with interstitial lung disease are at risk of radiation pneumonitis and should not receive drugs which can worsen the respiratory insufficiency. Patients who belong to what are called "special populations", e.g. elderly or HIV infected, should be treated specifically, especially regarding systemic treatment. Last but not least, psychosocial factors are of great importance and can vary from one country to another according to health insurance coverage.
引用
- Leduc C, Antoni D, Charloux A, et al. Comorbidities in the management of patients with lung cancer. Eur Respir J. 2017. PMID: 28356370. doi:10.1183/13993003.01721-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。